Video

Exploring Combination Drug Exposure for Epileptic Pregnant Women

Author(s):

Kimford J. Meador, MD speaks about the neurodevelopment effects of combination drug exposure in women with epilepsy at the American Epilepsy Association 2014 Annual Meeting.

Kimford J. Meador, MD speaks about the neurodevelopment effects of combination drug exposure in women with epilepsy at the American Epilepsy Association 2014 Annual Meeting.

Meador commented, "There are a lot of seizure medications that we don't understand the risks or the combinations very well. Most women with epilepsy go through pregnancy on a single drug, but there's a reasonable subset of anywhere from 20-33% of women that are on polytherapy and we don't know those combinations may increase risks."

Related Videos
Shawn Kwatra, MD: Making the Connection Between Prurigo Nodularis, Atopic Dermatitis, and Itch
Will Herrington, MBBS, MD, MA: Empagliflozin Follow-up Data Informs Clinical Care for CKD
Jennifer Lai Yee, MD, PhD, MPH: Honing in on Sparsentan’s Benefit in Genetic FSGS
Highlighting Recent Therapies for Dermatologists, with James Del Rosso, DO
Ladan Zand, MD: Obinutuzumab Promising Option for Refractory, Primary FSGS
Rahul N. Khurana, MD: Phase 1 Results on Vamikibart for Uveitic Macular Edema | Image Credit: Northern California Retina Vitreous Associates
Sunir J. Garg, MD: | Image Credit: Wills Eye Hospital
James Del Rosso, DO: Discussing What’s New in the Medicine Chest for Dermatologists
What to Look Forward To at the Fall Clinical Dermatology Conference, with Raj Chovatiya, MD, PhD
© 2024 MJH Life Sciences

All rights reserved.